Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Rosabella Moringa FDA recall supplement salmonella

FDA investigating outbreak of ‘extensively’ antibiotic resistant salmonella linked to supplement

Capsules of moringa tree leaf, branded as Rosabella, are being recalled after seven states report cases of the illness, with three patients saying they took the supplement. The company has issued an emergency recall. 

money cost cutting Medicare scissors dollar economics

Cardiology, cardiac imaging groups support new bill delaying cuts to physician pay

Nearly 40 healthcare organizations signed a letter in support of the bipartisan legislation, noting that Medicare's “efficiency adjustment” decreases reimbursement during a challenging time for physicians.

AI-powered MRI evaluations predict STEMI outcomes better than existing risk scores

Researchers found that their advanced machine learning model consistently outperformed current risk stratification techniques.

dollar money graph increase finance

Medtronic reports rising sales for cardiovascular devices—PFA tech leads the way

Medtronic's third quarter included a boom in PFA sales and a significant investment in Anteris Technologies. CEO Geoff Martha said the company hopes to make an even bigger impact in the structural heart space as time goes on.

Medtronic's Evolut Pro TAVR valve treating aortic stenosis

TAVR linked to higher reintervention rate than SAVR in Evolut Low Risk trial update

The Evolut Low Risk trial has been one of cardiology’s most closely watched studies for years now. For the first five years after treatment, TAVR and SAVR were associated with comparable outcomes when treating low-risk patients. In this new six-year update, however, TAVR was linked to a heightened risk of reintervention not seen with SAVR. 

The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for a 12-lead electrocardiogram (ECG) synthesis software for home assessment of arrhythmias. This clearance follows HeartBeam’s successful appeal of a prior "not substantially equivalent (NSE) determination.

FDA clears 12-lead, cable-free home ECG monitoring system

The new technology synthesizes signals from a credit card-sized device into a 12-lead ECG representation. 

CT findings linked with pancreatic cancer

FDA approves medical device for pancreatic cancer therapy—the first new treatment in 30 years

Developed by Novocure, the portable Optune Pax system uses tumor treating fields aimed directly at the site of the cancer to disrupt cell reproduction. A Phase 3 clinical trial shows it improves survival by two months on average versus chemotherapy alone.

Report: Epstein enjoyed close relationship with New York health system, to the benefit of his friends

Politico took a deep dive into the "Epstein Files" and found the criminal financier donated $250,000 to Mount Sinai after his 2008 conviction for sex crimes.  

Displaying 41 - 48 of 7132
Design by Adaptive Theme